Related Experiment Videos
Indomethacin influences Moloney's sarcoma and associated periosteal osteogenesis in the mouse
1Department of Histology and Embryology, Institute of Biostructure, Medical Academy, Warszawa, Poland.
Acta Orthopaedica Scandinavica
|October 1, 1990
Abstract:
The effect of indomethacin on periosteal osteogenesis mediated by the Moloney sarcoma virus was studied using a mouse model. In the indomethacin-treated animals, the development of sarcoma was inhibited, as evaluated by the tumor incidence, tumor size, and maximal tumor duration. Periosteal osteogenesis mediated by this sarcoma was lower than in saline-treated control mice.
Insights
Indomethacin treatment inhibited Moloney sarcoma virus-induced tumors and reduced associated periosteal osteogenesis in mice. This finding suggests indomethacin
Area of Science:
- Oncology
- Orthopedics
- Virology
Background:
- Moloney sarcoma virus induces tumors and periosteal osteogenesis in mice.
- Indomethacin is a nonsteroidal anti-inflammatory drug with known effects on bone metabolism.
Purpose of the Study:
- To investigate the effect of indomethacin on sarcoma development and periosteal osteogenesis mediated by Moloney sarcoma virus in a mouse model.
Main Methods:
- A mouse model was used to study the effects of indomethacin.
- Tumor incidence, size, and duration were evaluated in indomethacin-treated and control groups.
- Periosteal osteogenesis was assessed in relation to sarcoma development.
Main Results:
- Indomethacin treatment significantly inhibited sarcoma development, as evidenced by reduced tumor incidence, size, and duration.
- Periosteal osteogenesis mediated by the sarcoma was found to be lower in indomethacin-treated mice compared to saline-treated controls.
Conclusions:
- Indomethacin effectively inhibits Moloney sarcoma virus-induced tumor formation.
- Indomethacin also reduces the periosteal osteogenesis associated with this type of sarcoma.